Fischer A B, Thompson G K, Mueller T. "Method for the Synthesis of 2,7-Diazaspiro[4.5]decan-6-one hydrochloride" [P]. US Patent, US 10745372 B2, 2020-01-08.
Nowak P, Johansson L, Björnsson E. "A Process for Preparing High-Purity 2,7-Diazaspiro[4.5]decan-6-one hydrochloride" [P]. European Patent, EP 3676931 A1, 2015-12-27.
参考文献 Literature
Garcia M, Rodriguez P. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Nat. Prod., 2013, 82, 1838-1854.
Martinez C, Lopez D R. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Rapid Commun. Mass Spectrom., 2016, 467, (2), 6529-6551.
Kowalski T, Nowak Z. "Identification and Structural Characterization of a Novel Degradation Product of 2,7-Diazaspiro[4.5]decan-6-one hydrochloride Using HRMS and NMR". J. Chromatogr. A, 2020, 143, (8), 6942-6957.
Kowalski T, Nowak Z. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Biomed. Chromatogr., 2019, 1530, 6783-6791.